Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sarepta Therapeutics (SRPT)
NASDAQ:SRPT
Holding SRPT?
Track your performance easily
See the Price Targets and Ratings of:
SRPT Analyst Ratings
Strong Buy
18 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
SRPT Stock 12 Month Forecast
Average Price Target
$187.60
▲(64.10% Upside)
| Highest Price Target$210.00 | Average Price Target$187.60 | Lowest Price Target$150.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
J.P. Morgan
Reiterated
11/11/24
Barclays
Reiterated
11/08/24
TD Cowen
Assigned
11/07/24
Guggenheim
Reiterated
11/07/24
Evercore ISI
Assigned
11/07/24
William Blair
Reiterated
11/07/24
Mizuho Securities
Reiterated
11/07/24
Morgan Stanley
Reiterated
11/07/24
Piper Sandler
Assigned
11/07/24
Needham
Reiterated
11/07/24
Cantor Fitzgerald
$152→$167
Buy
46.08%
Upside
Upgraded
11/06/24
Sarepta Therapeutics: Strong Growth and Strategic Focus Justify Buy Rating
Leerink Partners
$210
Buy
83.69%
Upside
Reiterated
11/06/24
Sarepta Therapeutics: Strong Elevidys Sales Drive Buy Rating Amid Portfolio Optimism and Favorable Valuation
RBC Capital
$182
Buy
59.20%
Upside
Reiterated
11/06/24
RBC Capital Reaffirms Their Buy Rating on Sarepta Therapeutics (SRPT)
Bank of America Securities
$210
Buy
83.69%
Upside
Reiterated
11/06/24
Analysts Offer Insights on Healthcare Companies: RegenXBio (NASDAQ: RGNX), Sarepta Therapeutics (NASDAQ: SRPT) and Syndax Pharmaceuticals (NASDAQ: SNDX)
Robert W. Baird
$193
Buy
68.82%
Upside
Reiterated
11/06/24
Sarepta price target lowered to $193 from $200 at BairdSarepta price target lowered to $193 from $200 at Baird
Best Analysts Covering Sarepta Therapeutics
Which Analyst Should I Follow If I Want to Buy SRPT and Sell After:
1 Month
xxx
Success Rate
31/49 ratings generated profit
Average Return
+3.32%
reiterated a xxx
rating 17 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 63.27% of your transactions generating a profit, with an average return of +3.32% per trade.
3 Months
xxx
Success Rate
16/26 ratings generated profit
Average Return
+9.96%
reiterated a xxx
rating 17 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 61.54% of your transactions generating a profit, with an average return of +9.96% per trade.
1 Year
Success Rate
17/26 ratings generated profit
Average Return
+19.12%
reiterated a buy rating 17 days ago
Copying Joseph Schwartz's trades and holding each position for 1 Year would result in 65.38% of your transactions generating a profit, with an average return of +19.12% per trade.
2 Years
xxx
Success Rate
15/26 ratings generated profit
Average Return
+20.68%
reiterated a xxx
rating 17 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 57.69% of your transactions generating a profit, with an average return of +20.68% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
SRPT Analyst Recommendation Trends
Rating
Jul 24
Aug 24
Sep 24
Oct 24
Nov 24
Strong Buy
2
8
9
19
21
Buy
48
40
18
17
13
Hold
7
6
3
3
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
57
54
30
39
35
Each month's total comprises the sum of three months' worth of ratings.
SRPT Financial Forecast
SRPT Stock Forecast FAQ
What is SRPT’s average 12-month price target, according to analysts?
Based on analyst ratings, Sarepta Therapeutics’s 12-month average price target is $187.60.
What is SRPT’s upside potential, based on the analysts’ average price target?
Sarepta Therapeutics has 64.10% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is SRPT a Buy, Sell or Hold?
Sarepta Therapeutics has a consensus rating of Strong Buy which is based on 18 buy ratings, 0 hold ratings and 0 sell ratings.
What is Sarepta Therapeutics’s price target?
The average price target for Sarepta Therapeutics is $187.60. This is based on 18 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $210.00 ,the lowest forecast is $150.00. The average price target represents 64.10% Increase from the current price of $114.32.
The highest analyst price target is $210.00 ,the lowest forecast is $150.00. The average price target represents 64.10% Increase from the current price of $114.32.
What do analysts say about Sarepta Therapeutics?
Sarepta Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 18 Wall Streets Analysts.
How can I buy shares of SRPT?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.